Salmones Camanchaca S.A (SALMOCAM) Fair Value & Analysis
Consumer Defensive · CL · Market cap 393B CLP
Fair value as of: Jul 21, 2026
From 20 valuation models · updated 21 days ago
Fair value updated Jul 21, 2026, revised from 4,711 CLP to 4,771 CLP (+1.3%) since Jun 24, 2026. Share price −4.4% over the past month.
A solid business, currently priced close to our fair value.
What matters now
- The model range is unusually wide (2,698 CLP to 8,066 CLP). The outcome hinges heavily on assumptions, so read the point estimate with caution.
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 21, 2026.
How to read this chart
60‑month range 1,759 CLP – 5,496 CLP · fair‑value band 2,698 CLP – 8,066 CLP · the 4,970 CLP price screens above the 4,771 CLP fair value. Dashed = 300-day average. As of Jul 21, 2026.
Analysis
Salmones Camanchaca S.A (SALMOCAM) currently trades at 4,970 CLP, while our model-based Fair Value estimate is 4,771 CLP, implying the stock looks roughly 4.0% fairly valued today. The Quality Score stands at 64/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, Salmones Camanchaca S.A generated revenue of 388M CLP at a net margin of 4.6%. Revenue grew 2.3% year over year. It earns a return on equity of 8.2%. Net debt stands at 92.7M CLP. Fundamentals as of Jul 21, 2026
Our scenario range runs from 2,698 CLP (bear case) to 8,066 CLP (bull case); at 4,970 CLP, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 6% below its 52-week high and 76% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at 102% fair-value upside, at -4%, SALMOCAM screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 20 models by family
Widest divergence: Multiples (6,907 CLP) versus Asset-Based (2,137 CLP). Highest evidence: Residual Income (76).
Notify me when SALMOCAM reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 21, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 63 · Market factors (momentum, volatility) 90
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The company offers Atlantic salmon, including whole/HG, steak, servings, and other products; and whole/HG coho, coho steak, and coho portions. It also exports its products. The company was founded in 1987 and is based in Puerto Montt, Chile. Salmones Camanchaca S.A.
Full company description
Salmones Camanchaca S.A. engages in the salmon farming business in Chile. The company offers Atlantic salmon, including whole/HG, steak, servings, and other products; and whole/HG coho, coho steak, and coho portions. It also exports its products. The company was founded in 1987 and is based in Puerto Montt, Chile. Salmones Camanchaca S.A. operates as a subsidiary of Camanchaca S.A.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Salmones Camanchaca S.A reported revenue of 386M CLP in FY2025 versus 294M CLP in FY2021, a compound +7.1%/yr. Reported net income was 25.5M CLP in FY2025.
Watch SALMOCAM: get an alert when its fair value changes →
Peer Group
Farm Products · 288 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Farm Products median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Jul 21, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Muyuan Foods Group 002714 | ¥40.90 | ¥48.19 | +18% |
| Wens Foodstuff Group 300498 | ¥14.51 | ¥12.08 | -17% |
| Mowi ASA MOWI | kr 188.40 | kr 262.59 | +39% |
| PT Charoen Pokphand Indonesia Tbk, CPIN | 3,120 IDR | 7,076 IDR | +127% |
| Charoen Pokphand Foods Public Company CPF | 22.00 THB | 55.71 THB | +153% |
| PT Triputra Agro Persada Tbk TAPG | 1,540 IDR | 3,105 IDR | +102% |
| PT FAP Agri Tbk FAPA | 7,300 IDR | 7,463 IDR | +2% |
| PT Japfa Comfeed Indonesia Tbk JPFA | 2,070 IDR | 7,231 IDR | +249% |
| Thaifoods Group TFGR | 10.60 THB | 23.53 THB | +122% |
| PT Jhonlin Agro Raya Tbk JARR | 1,845 IDR | 610.80 IDR | -67% |
Compare Salmones Camanchaca S.A with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Salmones Camanchaca S.A (SALMOCAM) overvalued or undervalued?
What is the fair value of SALMOCAM?
What is the quality score of SALMOCAM?
What is the revenue of Salmones Camanchaca S.A (SALMOCAM)?
What is the net profit margin of SALMOCAM?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Salmones Camanchaca S.A and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.